Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia
Authors:
- Emiliano LeoneELEmiliano Leone
- Gabriele BajGBGabriele Baj
- Enrico TongiorgiEnrico Tongiorgi
- Maurizio De VannaMVMaurizio De Vanna
- 1 February 2011
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 45 (2) , 273-279
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Decreased BDNF in patients with antipsychotic naïve first episode schizophreniaSchizophrenia Research, 2010
- Is Serum Brain-Derived Neurotrophic Factor a Biomarker for Cognitive Enhancement in Schizophrenia?Biological Psychiatry, 2009
- Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survivalMolecular Brain, 2009
- SchizophreniaThe Lancet, 2009
- Abbreviated neuropsychological assessment in schizophrenia: Prediction of different aspects of outcomeJournal of Clinical and Experimental Neuropsychology, 2009
- Predicting Schizophrenia Patients’ Real-World Behavior with Specific Neuropsychological and Functional Capacity MeasuresBiological Psychiatry, 2008
- Serum neurotrophins—A study on the time course and influencing factors in a large old age sampleNeurobiology of Aging, 2007
- Neurotrophins and schizophreniaSchizophrenia Research, 2007
- Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorderNeuroscience Letters, 2007
- Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychosesJournal of Neural Transmission, 1998